$LEU
CENTRUS ENERGY CORP

2021 Q3 Form 10-Q Financial Statement

#000106505921000047 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $91.30M $92.90M $33.60M
YoY Change 171.73% 66.79% -67.91%
Cost Of Revenue $41.80M $57.90M $34.40M
YoY Change 21.51% 18.4% -50.29%
Gross Profit $49.50M $35.00M -$800.0K
YoY Change -6287.5% 414.71% -102.25%
Gross Profit Margin 54.22% 37.67% -2.38%
Selling, General & Admin $9.000M $10.40M $6.700M
YoY Change 34.33% 13.04% -22.99%
% of Gross Profit 18.18% 29.71%
Research & Development $600.0K $1.000M $200.0K
YoY Change 200.0% -37.5% -84.62%
% of Gross Profit 1.21% 2.86%
Depreciation & Amortization $1.800M $2.600M $1.300M
YoY Change 38.46% 4.0% -31.58%
% of Gross Profit 3.64% 7.43%
Operating Expenses $9.600M $11.40M $6.900M
YoY Change 39.13% 5.56% -31.0%
Operating Profit $38.20M $20.60M -$9.500M
YoY Change -502.11% -407.46% -141.13%
Interest Expense $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% -125.0%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $4.300M -$5.000M $2.200M
YoY Change 95.45% -221.95% 2100.0%
Pretax Income $42.50M $15.60M -$7.200M
YoY Change -690.28% -750.0% -131.58%
Income Tax $400.0K -$800.0K -$200.0K
% Of Pretax Income 0.94% -5.13%
Net Earnings $42.10M $16.40M -$7.000M
YoY Change -701.43% -685.71% -130.7%
Net Earnings / Revenue 46.11% 17.65% -20.83%
Basic Earnings Per Share $3.01 -$2.55 -$0.83
Diluted Earnings Per Share $2.95 -$2.55 -$0.83
COMMON SHARES
Basic Shares Outstanding 13.74M shares 11.32M shares 10.72M shares
Diluted Shares Outstanding 14.06M shares 10.72M shares

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $171.0M $152.0M $152.8M
YoY Change 11.91% 16.3% 97.93%
Cash & Equivalents $171.0M $152.0M $152.8M
Short-Term Investments
Other Short-Term Assets $9.100M $7.800M $7.400M
YoY Change 22.97% -15.22% -70.98%
Inventory $80.00M $64.80M $66.60M
Prepaid Expenses
Receivables $16.90M $29.60M $14.10M
Other Receivables $12.70M $23.00M $6.000M
Total Short-Term Assets $414.2M $406.1M $386.3M
YoY Change 7.22% 9.88% 6.39%
LONG-TERM ASSETS
Property, Plant & Equipment $5.300M $4.900M $4.400M
YoY Change 20.45% 32.43% 15.79%
Goodwill
YoY Change
Intangibles $57.40M $62.80M $65.20M
YoY Change -11.96% -9.64% -9.32%
Long-Term Investments
YoY Change
Other Assets $4.600M $4.900M $6.600M
YoY Change -30.3% -33.78% -1.49%
Total Long-Term Assets $73.00M $80.20M $81.90M
YoY Change -10.87% -7.07% -7.04%
TOTAL ASSETS
Total Short-Term Assets $414.2M $406.1M $386.3M
Total Long-Term Assets $73.00M $80.20M $81.90M
Total Assets $487.2M $486.3M $468.2M
YoY Change 4.06% 6.67% 3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $21.30M $0.00
YoY Change 162.96% -100.0%
Accrued Expenses $44.70M $50.60M $52.20M
YoY Change -14.37% -0.2% 2510.0%
Deferred Revenue $275.2M $283.2M $249.7M
YoY Change 10.21% 6.35% 971.67%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $6.100M $6.100M $6.100M
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $335.2M $366.1M $315.8M
YoY Change 6.14% 8.7% -4.62%
LONG-TERM LIABILITIES
Long-Term Debt $101.8M $108.0M $108.0M
YoY Change -5.74% -5.35% -5.35%
Other Long-Term Liabilities $34.00M $32.40M $22.60M
YoY Change 50.44% 0.93% -0.44%
Total Long-Term Liabilities $34.00M $32.40M $22.60M
YoY Change 50.44% -95.91% -97.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $335.2M $366.1M $315.8M
Total Long-Term Liabilities $34.00M $32.40M $22.60M
Total Liabilities $716.3M $806.9M $743.8M
YoY Change -3.7% 1.78% -33.45%
SHAREHOLDERS EQUITY
Retained Earnings -$356.5M -$407.7M -$367.0M
YoY Change -2.86% 0.67% -8.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$229.1M -$320.6M -$275.6M
YoY Change
Total Liabilities & Shareholders Equity $487.2M $486.3M $468.2M
YoY Change 4.06% 6.67% 3.77%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income $42.10M $16.40M -$7.000M
YoY Change -701.43% -685.71% -130.7%
Depreciation, Depletion And Amortization $1.800M $2.600M $1.300M
YoY Change 38.46% 4.0% -31.58%
Cash From Operating Activities -$2.100M $61.90M $13.60M
YoY Change -115.44% 63.76% -26.88%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$500.0K -$800.0K
YoY Change -100.0% 400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$500.0K -$800.0K
YoY Change -100.0% 400.0% -500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.900M -62.20M 20.70M
YoY Change -114.01% 5083.33% -167.43%
NET CHANGE
Cash From Operating Activities -2.100M 61.90M 13.60M
Cash From Investing Activities 0.000 -500.0K -800.0K
Cash From Financing Activities -2.900M -62.20M 20.70M
Net Change In Cash -5.000M -800.0K 33.50M
YoY Change -114.93% -102.19% -381.51%
FREE CASH FLOW
Cash From Operating Activities -$2.100M $61.90M $13.60M
Capital Expenditures $0.00 -$500.0K -$800.0K
Free Cash Flow -$2.100M $62.40M $14.40M
YoY Change -114.58% 64.64% -22.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001065059
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2800000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2700000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-14287
dei Entity Registrant Name
EntityRegistrantName
Centrus Energy Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2107911
dei Entity Address Address Line1
EntityAddressAddressLine1
6901 Rockledge Drive,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800,
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20817
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
564-3200
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.10 per share
dei Trading Symbol
TradingSymbol
LEU
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171000000.0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152000000.0 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16900000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29600000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
80000000.0 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
64800000 USD
CY2021Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
137200000 USD
CY2020Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
151900000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9100000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7800000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
414200000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
406100000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5300000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4900000 USD
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5700000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5700000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
57400000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62800000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4600000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6800000 USD
CY2021Q3 us-gaap Assets
Assets
487200000 USD
CY2020Q4 us-gaap Assets
Assets
486300000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44700000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50600000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2200000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21300000 USD
CY2021Q3 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
7000000.0 USD
CY2020Q4 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
4900000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
275200000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
283200000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
6100000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
6100000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
335200000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
366100000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
101800000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
108000000.0 USD
CY2021Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
124300000 USD
CY2020Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
130800000 USD
CY2021Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
75900000 USD
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
124400000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
45100000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
45200000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34000000.0 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32400000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
716300000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
806900000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
125400000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85000000.0 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356500000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407700000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
500000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
800000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-229100000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-320600000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487200000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
486300000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
91300000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
33600000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209300000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154300000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41800000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34400000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
131000000.0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91700000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
49500000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-800000 USD
us-gaap Gross Profit
GrossProfit
78300000 USD
us-gaap Gross Profit
GrossProfit
62600000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
600000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1800000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9000000.0 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6700000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25000000.0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25600000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000 USD
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
600000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
500000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38200000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
46600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
30400000 USD
CY2021Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-4300000 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-2200000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-12900000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-6600000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
100000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
500000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42500000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37400000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
42100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
58800000 USD
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
CY2021Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
700000 USD
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2100000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
CY2021Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
CY2020Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
6600000 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
41400000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8900000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32100000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.95
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13741000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10723000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13365000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10008000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14056000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10723000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13702000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10282000 shares
us-gaap Net Income Loss
NetIncomeLoss
58800000 USD
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5800000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 USD
us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-4800000 USD
us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12700000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7000000.0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17100000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7200000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-300000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-19000000.0 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-8100000 USD
leu Increase Decreasein Deferred Revenue Netof Deferred Costs
IncreaseDecreaseinDeferredRevenueNetofDeferredCosts
-8600000 USD
leu Increase Decreasein Deferred Revenue Netof Deferred Costs
IncreaseDecreaseinDeferredRevenueNetofDeferredCosts
-17500000 USD
leu Accruedlossonlongtermcontractincreasedecrease
Accruedlossonlongtermcontractincreasedecrease
-6500000 USD
leu Accruedlossonlongtermcontractincreasedecrease
Accruedlossonlongtermcontractincreasedecrease
-8700000 USD
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-55300000 USD
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-28100000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1300000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-900000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27200000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23800000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
500000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
6100000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
6100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18900000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17800000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19000000.0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22100000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157900000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136600000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176900000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158700000 USD
us-gaap Notes Issued1
NotesIssued1
7500000 USD
us-gaap Notes Issued1
NotesIssued1
0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-336900000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-325400000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
33700000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-291700000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-275600000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-320600000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5100000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23800000 USD
CY2021Q1 leu Receivable From Issuance Of Stock
ReceivableFromIssuanceOfStock
700000 USD
CY2021Q1 leu Exchange Of Preferred Stock For Common Stock And Common Stock Warrant
ExchangeOfPreferredStockForCommonStockAndCommonStockWarrant
-100000 USD
CY2021Q1 leu Reclassification Of Stock Based Compensation Liability To Equity
ReclassificationOfStockBasedCompensationLiabilityToEquity
7500000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-284800000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
11600000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3500000 USD
CY2021Q2 leu Receivable From Issuance Of Stock
ReceivableFromIssuanceOfStock
-700000 USD
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
2400000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-271400000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
42100000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-229100000 USD
CY2021Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
12700000 USD
CY2020Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
23000000.0 USD
CY2021Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4200000 USD
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
6600000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16900000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29600000 USD
leu Provision For Loss On Contract Change
ProvisionForLossOnContractChange
-5800000 USD
leu Provision For Loss On Contract Noncurrent Change
ProvisionForLossOnContractNoncurrentChange
-700000 USD
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
259100000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
281700000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-22600000 USD
CY2021Q3 leu Advancesfromcustomerscurrent
Advancesfromcustomerscurrent
16100000 USD
CY2020Q4 leu Advancesfromcustomerscurrent
Advancesfromcustomerscurrent
1500000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
14600000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
45100000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
45200000 USD
leu Increasedecreasein Advancesfromcustomersnoncurrent
IncreasedecreaseinAdvancesfromcustomersnoncurrent
-100000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
28500000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
960000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
960000000 USD
CY2020Q4 leu Separative Work Units Owed To Others
SeparativeWorkUnitsOwedToOthers
20700000 USD
CY2021Q3 leu Separative Work Units Owed To Others
SeparativeWorkUnitsOwedToOthers
25500000 USD
CY2021Q3 leu Separative Work Units Owed To Others Current
SeparativeWorkUnitsOwedToOthersCurrent
3000000 USD
CY2021Q3 leu Separativeworkunitsowedtoothersnoncurrent
Separativeworkunitsowedtoothersnoncurrent
22500000 USD
CY2021Q3 leu Separative Work Units Owed To Others Valuation Adjustment
SeparativeWorkUnitsOwedToOthersValuationAdjustment
4800000 USD
CY2021Q3 leu Provision For Loss On Contracts Utilized
ProvisionForLossOnContractsUtilized
6500000 USD
leu Provision For Loss On Contracts Utilized
ProvisionForLossOnContractsUtilized
8700000 USD
CY2021Q3 leu Provision For Loss On Contracts Total
ProvisionForLossOnContractsTotal
1200000 USD
CY2021Q3 leu Governmentcostshareportion
Governmentcostshareportion
117900000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
43500000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171000000.0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152800000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5700000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5700000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176900000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158700000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
80000000.0 USD
CY2021Q3 leu Separative Work Units Inventory
SeparativeWorkUnitsInventory
13000000.0 USD
CY2021Q3 leu Separative Work Units Owed To Customers And Suppliers
SeparativeWorkUnitsOwedToCustomersAndSuppliers
100000 USD
CY2021Q3 leu Separative Work Units Net Of Liability
SeparativeWorkUnitsNetOfLiability
12900000 USD
CY2020Q4 leu Separative Work Units Inventory
SeparativeWorkUnitsInventory
17000000.0 USD
CY2020Q4 leu Separative Work Units Owed To Customers And Suppliers
SeparativeWorkUnitsOwedToCustomersAndSuppliers
4600000 USD
CY2020Q4 leu Separative Work Units Net Of Liability
SeparativeWorkUnitsNetOfLiability
12400000 USD
CY2021Q3 leu Uranium Inventory
UraniumInventory
67000000.0 USD
CY2021Q3 leu Uranium Owed To Customers And Suppliers
UraniumOwedToCustomersAndSuppliers
6900000 USD
CY2021Q3 leu Uranium Inventory Net Of Liability
UraniumInventoryNetOfLiability
60100000 USD
CY2020Q4 leu Uranium Inventory
UraniumInventory
47800000 USD
CY2020Q4 leu Uranium Owed To Customers And Suppliers
UraniumOwedToCustomersAndSuppliers
300000 USD
CY2020Q4 leu Uranium Inventory Net Of Liability
UraniumInventoryNetOfLiability
47500000 USD
CY2021Q3 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
7000000.0 USD
CY2021Q3 leu Inventory Net Of Liability
InventoryNetOfLiability
73000000.0 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
64800000 USD
CY2020Q4 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
4900000 USD
CY2020Q4 leu Inventory Net Of Liability
InventoryNetOfLiability
59900000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
123500000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
66100000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
57400000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
123500000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
60700000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62800000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171000000.0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
171000000.0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
152000000.0 USD
CY2021Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
3000000.0 USD
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
2400000 USD
CY2021Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
2800000 USD
CY2020Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
2300000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
43500000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.62
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1291.04
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
6600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
42100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
CY2020Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
us-gaap Net Income Loss
NetIncomeLoss
58800000 USD
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
CY2021Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
700000 USD
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2100000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
CY2021Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
6600000 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
41400000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8900000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32100000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13741000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10723000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13365000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10008000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
315000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
337000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
274000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14056000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10723000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13702000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10282000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.95
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
317000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q3 leu Stock Issued During Period Value Gross
StockIssuedDuringPeriodValueGross
28700000 USD
CY2021Q3 leu Stock Issued During Period Value Net
StockIssuedDuringPeriodValueNet
27600000 USD
CY2021Q3 leu Direct Costs Of Stock Issuance
DirectCostsOfStockIssuance
400000 USD
CY2021Q3 leu Shares Reserved For Share Based Payment Increase
SharesReservedForShareBasedPaymentIncrease
700000 shares
CY2021Q3 leu Preferred Stock Retired Liquidation Preference
PreferredStockRetiredLiquidationPreference
5000198 USD
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.62
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
250000 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.62
CY2021Q3 leu Reclassification Of Stock Based Compensation Liability To Equity
ReclassificationOfStockBasedCompensationLiabilityToEquity
7500000 USD
CY2021Q3 us-gaap Loss Contingency Range Of Possible Loss Portion Not Accrued
LossContingencyRangeOfPossibleLossPortionNotAccrued
9600000 USD
CY2020Q4 us-gaap Gain Contingency Unrecorded Amount
GainContingencyUnrecordedAmount
42800000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
43500000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91300000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33600000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209300000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154300000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
49500000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-800000 USD
us-gaap Gross Profit
GrossProfit
78300000 USD
us-gaap Gross Profit
GrossProfit
62600000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q3 leu Preferred Stock Tender Offer Per Share
PreferredStockTenderOfferPerShare
1145.2
CY2021Q3 leu Preferred Stock Tender Offer Per Share
PreferredStockTenderOfferPerShare
1145.2
CY2021Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1347.29
CY2021Q3 leu Preferred Stock Tender Offer Maximum
PreferredStockTenderOfferMaximum
43342384 USD
CY2021Q3 leu Preferred Stock Tender Offer Per Share
PreferredStockTenderOfferPerShare
1145.2

Files In Submission

Name View Source Status
0001065059-21-000047-index-headers.html Edgar Link pending
0001065059-21-000047-index.html Edgar Link pending
0001065059-21-000047.txt Edgar Link pending
0001065059-21-000047-xbrl.zip Edgar Link pending
exhibit101_20210930.htm Edgar Link pending
exhibit102_20210930.htm Edgar Link pending
exhibit103_20210930.htm Edgar Link pending
exhibit_31-1x20210930.htm Edgar Link pending
exhibit_31-2x20210930.htm Edgar Link pending
exhibit_32-1x20210930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image.jpg Edgar Link pending
image1.jpg Edgar Link pending
image1b.jpg Edgar Link pending
image2a.jpg Edgar Link pending
image3a.jpg Edgar Link pending
image4a.jpg Edgar Link pending
image5a.jpg Edgar Link pending
imageb.jpg Edgar Link pending
leu-20210930.htm Edgar Link pending
leu-20210930.xsd Edgar Link pending
leu-20210930_cal.xml Edgar Link unprocessable
leu-20210930_def.xml Edgar Link unprocessable
leu-20210930_g1.jpg Edgar Link pending
leu-20210930_htm.xml Edgar Link completed
leu-20210930_lab.xml Edgar Link unprocessable
leu-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending